Replimune Group Inc REPL:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
Last | 10:06 AM EDT
33.71quote price arrow down-0.96 (-2.77%)
Volume
17,009
52 week range
18.40 - 54.85

...

Loading . . .
  • Open34.58
  • Day High34.58
  • Day Low33.71
  • Prev Close34.67
  • 52 Week High54.85
  • 52 Week High Date11/19/20
  • 52 Week Low18.40
  • 52 Week Low Date07/28/20

Key Stats

  • Market Cap1.571B
  • Shares Out46.61M
  • 10 Day Average Volume0.43M
  • Dividend-
  • Dividend Yield-
  • Beta2.53
  • YTD % Change-10.72

KEY STATS

  • Open34.58
  • Day High34.58
  • Day Low33.71
  • Prev Close34.67
  • 52 Week High54.85
  • 52 Week High Date11/19/20
  • 52 Week Low18.40
  • 52 Week Low Date07/28/20
  • Market Cap1.571B
  • Shares Out46.61M
  • 10 Day Average Volume0.43M
  • Dividend-
  • Dividend Yield-
  • Beta2.53
  • YTD % Change-10.72

RATIOS/PROFITABILITY

  • EPS (TTM)-1.75
  • P/E (TTM)-19.24
  • Fwd P/E (NTM)-18.48
  • EBITDA (MRQ)-75.826M
  • ROE (MRQ)-23.70%
  • Revenue (MRQ)0.00
  • Gross Margin (MRQ)-
  • Net Margin (MRQ)-
  • Debt To Equity (MRQ)5.46%

EVENTS

  • Earnings Date08/18/2021
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Replimune Group Inc

There is no recent news for this security.

Profile

MORE
Replimune Group, Inc. is a clinical-stage biotechnology company. The Company is engaged in the field of oncolytic immunotherapy to treat the cancer patients. The Company applies its Immulytic platform to design and develop product candidates that are intended to maximally activate the immune system against solid tumors. The Company is focused on developing a pipeline of oncolytic immunotherapy product candidates to provide clinical benefits to cancer patients. Its product...
Dieter Weinand
Chairman
Philip Astley-Sparke
Chief Executive Officer
Robert Coffin Ph.D.
President
Colin Love Ph.D.
Chief Operating Officer
Jean Franchi
Chief Financial Officer
Address
500 Unicorn Park Dr
Woburn, MA
01801-3377
United States

Top Peers

SYMBOLLASTCHG%CHG
AMTI
Applied Molecular Transport Inc.
49.87+0.87+1.78%
CNST
Constellation Pharmaceuticals Inc
33.75+0.05+0.15%
GBIO
Generation Bio Co
28.07+0.18+0.65%
KURA
Kura Oncology Inc
23.00-0.37-1.58%
ADCT
ADC Therapeutics SA
23.76+0.58+2.50%